CAH — Neutral (ASignal Rank 3/4)
ASignal's 10+ AI agent pipeline rates CAH as Neutral with 88% confidence in the Healthcare sector.
AI Analysis Summary
Cardinal Health (CAH) presents a mixed investment profile with conflicting signals between growth potential and structural risks. While strong free cash flow and market position offer appeal, weak liquidity, negative book value, and a bearish forecast create uncertainty.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade C — 55/100
- Bill Ackman (Activist Investing): Grade B — 66/100
- Ray Dalio (Macro/Risk Parity): Grade D — 42/100
Consensus: Neutral
Price Intelligence
- Current price: $205.62
- Price target: $204.09 (-0.7%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: excellent
- Competitive moat: efficient scale
Peer Group Analysis
CAH is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.